BMS reports flat revenue growth for full-year 2025

BMS achieved non-GAAP EPS of $6.15 for the full year, a substantial improvement from $1.15 in 2024. Credit: Piotr Swat / Shutterstock.com.



  • Bristol Myers Squibb BMS